All In MedTech

Device Trial Radar · NCT07940127

AI-Driven Hip Exoskeleton Control for Diverse Users and Walking Tasks

AI-Driven Hip Exoskeleton Control Framework That Rapidly Generalizes to a Broad Range of Users and Real-World Locomotor Tasks

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Aug 6, 2026

Primary completion

Aug 31, 2027

Study completion Jan 31, 2028

Sponsor

Lead sponsor
Carnegie Mellon UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute for Biomedical Imaging and Bioengineering (NIBIB); University of Texas at Austin
First posted
Nov 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the feasibility of a prototype artificial intelligence (AI)-based controller for a lightweight hip exoskeleton across a broad range of users, including healthy younger adults (18-39 years) and older adults (65 years and older). The main questions it aims to answer are: * Can the AI-based controller accurately estimate gait phase in real time across younger and older adults? * How does hip exoskeleton assistance change walking energy cost, mechanics, and muscle activity? Researchers will compare walking with powered hip exoskeleton assistance to walking without the exoskeleton and walking while wearing the exoskeleton with no assistance (zero torque). Participants will: * Complete a short screening and frailty assessment * Walk on a treadmill under different conditions with and without the hip exoskeleton during 2 to 5 lab visits * Wear motion capture markers, muscle activity (EMG) sensors, and a mask that measures breathing to estimate energy use

Conditions

  • Healthy Volunteers
  • Gait
  • Aging

Interventions

  • AI-Driven Hip Exoskeleton AssistanceDevice

    A lightweight (3.5 kg) research hip exoskeleton developed at Carnegie Mellon University with powered hip flexion/extension joints, a backpack-mounted computer and battery, and thigh and waist interfaces secured with straps. An AI-driven controller estimates the user's gait state from joint angle and wearable sensor data and commands assistive hip torque in real time, limited to \<0.2 Nm/kg (peak device torque 18 Nm). Participants walk on a treadmill with powered assistance, with the device worn at zero torque, and without the device. The device was determined by the UT Austin IRB to be a non-significant risk device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Gait Phase Estimation Error of the AI-Driven Hip Exoskeleton ControllerTime frame: Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas at Austin

    Austin, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.